-
Top 7 Biotech Stock Winners As Weight Loss Drug Battle Escalates: Goldman Sachs Names Best Picks
Wednesday, March 13, 2024 - 12:35pm | 589Read More...Goldman Sachs analysts are identifying a substantial opportunity in the manufacturing sector for new obesity therapeutics as demand escalates for these treatments. Goldman Sachs projects the global obesity market to potentially reach $100 billion by 2030, with a more optimistic outlook suggesting...
-
Gary Black Keeping Tabs On Oprah's Upcoming TV Special About Ozempic — 'Shame, Blame And The Weight Loss Revolution'
Tuesday, March 12, 2024 - 1:09am | 695Read More...Future Fund co-founder Gary Black on Monday shared information about legendary television mogul Oprah Winfrey’s upcoming TV special, where she will discuss her weight loss journey and the role of GLP-1 weight loss drugs. What Happened: Black, a well-known investor, took to X,...
-
S&P 500 Sets Sights On 5,400, But Analyst Warns Of Imminent Market Volatility
Monday, March 4, 2024 - 11:50am | 681Read More...Bank of America’s equity strategist Savita Subramanian on Sunday revised the year-end target for the S&P 500 to 5,400, up from the previous target of 5,000, signaling a modest 5% upside potential. Despite a more positive outlook, there’s an acknowledgment of the market’s...




